Pertuzumab for the treatment of patients with human epidermal growth factor receptor 2-positive breast cancer in Japan

Pertuzumab, a novel anti-human epidermal growth factor receptor 2 (HER2) agent, is effective for metastatic HER2-positive breast cancer when used in combination with taxane and trastuzumab. The aim of the present study was to describe the use of pertuzumab in Japan. A phase I clinical trial of pertu...

Descripción completa

Detalles Bibliográficos
Autores principales: OSAKO, TOMOFUMI, NISHIMURA, REIKI, NISHIYAMA, YASUYUKI, FUJISUE, MAMIKO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665969/
https://www.ncbi.nlm.nih.gov/pubmed/26807231
http://dx.doi.org/10.3892/mco.2015.640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665969/
https://www.ncbi.nlm.nih.gov/pubmed/26807231
http://dx.doi.org/10.3892/mco.2015.640

Ejemplares similares